MedPath

Treatment of Benign Prostatic Hyperplasia using Kushaadi Taila Matra Basti (in the form of enema) and Gokshura Kwath ( to be taken freshly prepared orally by the patient)

Not yet recruiting
Conditions
Benign prostatic hyperplasia without lower urinary tract symptoms. Ayurveda Condition: VATASHTHILA,
Registration Number
CTRI/2023/06/054495
Lead Sponsor
Uttarakhand Ayurved University
Brief Summary

BPH is a non- cancerous disease and it is a part of normal ageing process. The most widely acknowledged cause is an imbalance between androgen and estrogen. It cause symptoms like increased frequency of micturition in day as well as night time, urgency, etc. and signs like enlargement in Prostate size.

This study is a interventional, open level, single group trial, A Clinical study of Kushaadi Taila Matra Basti and Gokshura Kwath in Vatashtheela (Benign Prostatic Hyperplasia). The case will be selected randomly from OPD/IPD of Rishikul Campus Hospital, U.A.U, Haridwar (U.K.) India. The study will be intervened under one group with Kushaadi Taila (Matra Basti) and Gokshura Kwath (orally), duration of trial will be 21 days. Assessment criteria will be done on subjective and objective parameters. Subjective parameters on the basis of International prostate symptom score (IPSS) and objective parameters on residual urine volume and prostate size volume.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Male
Target Recruitment
34
Inclusion Criteria

1.Patients with classical signs and symptoms of Vatashtheela 2.Age group 50 years or above 50 years.

Exclusion Criteria
  • 1.Age below 50 years 2.Patient with acute retention 3.Known malignant condition of Uro-genital system 4.Patient associated with other systemic disorder- Renal failure, Malignancy, immuno-compromised patients etc.
  • 5.Patients not willing to undergo trial 6.Covid-19 non vaccinated patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief in the symptoms like frequency of urination in day & night time urgency of urination & relief in signs such as enlargement of Prostate7th 14th 21st day & after treatment
Secondary Outcome Measures
NameTimeMethod
Expected improvement in the quality of life of patients by relief in the symptoms like decrease in the number of Micturition by patient during day & night, Urgency, as well as expected relief in reduction of size of Prostate gland of Prostate7th 14th 21st day & after treatment

Trial Locations

Locations (1)

Rishikul Campus Haridwar

🇮🇳

Hardwar, UTTARANCHAL, India

Rishikul Campus Haridwar
🇮🇳Hardwar, UTTARANCHAL, India
Dr Kajal Saini
Principal investigator
8171072006
kajalsaini1227@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.